TP53 and neoplasm: Tamoxifen treatment lead to upregulation of p53 and p21, and a concomitant loss of GFP specifically in KPTR/TR;Rosa26FlpO-ER/+ but not KPTR/TR;Rosa26+/+ tumours (Fig. 3d).